Qualicaps launches QUALIS®-Professional, next-gen UV laser pill printing and inspection system globally in Nov 2025

NARA, JAPAN – Qualicaps, a number one pharmaceutical tools producer, introduces its newest UV laser pill printing and inspection system, QUALIS®-Pro¹, globally in November 2025. The brand new mannequin integrates proprietary UV laser printing expertise with a newly developed high-precision inspection system, providing enhanced manufacturing high quality and effectivity for the pharmaceutical and nutraceutical industries.

For over 20 years, Qualicaps has been a pioneer in UV laser printing expertise and has led the business via joint improvement with Eisai Co., Ltd².. Drawing upon our in depth expertise and technical experience, the QUALIS®-Professional has been designed as an entire replace to earlier fashions, incorporating enhancements in print high quality, inspection accuracy and operational effectivity.

UV Laser Printing – Sustainable and Exact

The system makes use of no ink, eliminating the necessity for cleansing and replenishment, decreasing operator workload, reducing working prices, and selling extra sustainable manufacturing processes. The printing expertise achieves a yield price of 99.99%, considerably minimizing materials loss. Key options of QUALIS®-Professional

Built-in inspection system – All-direction inspection together with facet surfaces of tablets, with 3D inspection, print verification and shape-adaptive printing alignment.
Excessive processing capability – As much as 400,000 tablets per hour, with inspection accuracy that may take away the necessity for a separate inspection machine.
Compact, all-in-one design – Constructed-in blower, chiller and management panel; footprint roughly 1.4 m (W) × 1.6 m (D) × 2.0 m (H).
Diminished spare components stock – Solely two interchangeable elements (rubber rings and monitor guides) are required, without having for product-specific components.

By combining superior printing and inspection in a single compact unit, QUALIS®-Professional allows producers to optimize manufacturing area, cut back labor necessities and guarantee constantly excessive product high quality.

¹ QUALIS is a registered trademark of Qualicaps Co., Ltd.

² Qualicaps Co., Ltd. has been granted unique licenses from Eisai Co., Ltd. for Japanese Patents No. 5339723, No. 5642100, and No. 5903141. Some applied sciences included on this system are coated by these patents; unauthorized imitation, manufacture, sale, or gives on the market could represent infringement. We ask that each one firms respect these patents and reply appropriately.

About Qualicaps Co. Ltd.

Qualicaps is a worldwide participant within the manufacturing and commercialization of exhausting capsules and pharmaceutical processing tools for the oral dosage market. With over 125 years of capsule manufacturing expertise and the introduction of a number of capsule improvements to the pharmaceutical market, Qualicaps is uniquely positioned to supply an integral service to its clients via its international crew of business, scientific, and technical specialists.

Acquired in October 2023, Qualicaps is a part of Roquette, a number one supplier of plant-based components, excipients and pharmaceutical options devoted to enhancing the standard and comfort of important merchandise for customers and sufferers worldwide. Roquette greater than 11,000 individuals globally, working in additional than 150 international locations via greater than 40 manufacturing websites and 20 R&D and innovation facilities..

For extra details about Roquette, go to: www.roquette.com

For extra info on Qualicaps, go to https://en.qualicaps.co.jp/

Filed in Medical. Learn extra about Japan and Press Release.